2016 Annual Meeting | Multiple Sclerosis Therapy: Disease-modifying Treatment I
| 01:00 PM - 01:50 PM |
DMT Switching: When and How to Think About Switching A Patient to Another Disease-modifying Therapy
Timothy W. West, MD |
|
| 01:50 PM - 02:40 PM |
Risk Stratification and Mitigation
Bruce A. Cree, MD, PhD, MAS, FAAN |
|
| 02:40 PM - 03:00 PM |
Case Discussion
|
| Timothy W. West, MD | Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. West has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD serono. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. |
| Bruce A. Cree, MD, PhD, MAS, FAAN | The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care. |